Wordt geladen...
Programmed death ligand-1 and MET co-expression is a poor prognostic factor in gastric cancers after resection
Programmed death-ligand 1 (PD-L1) plays an essential protein for immune evasion, contributing to tumor development and progression. Recent studies have reported MET as an upregulator for PD-L1 overexpression through an oncogenic pathway. However, an association between PD-L1 expression with MET has...
Bewaard in:
| Gepubliceerd in: | Oncotarget |
|---|---|
| Hoofdauteurs: | , , , , , , , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Impact Journals LLC
2017
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5669899/ https://ncbi.nlm.nih.gov/pubmed/29137273 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.19390 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|